268 related articles for article (PubMed ID: 28891012)
21. Quantification of
Kero T; Sörensen J; Antoni G; Wilking H; Carlson K; Vedin O; Rosengren S; Wikström G; Lubberink M
J Nucl Cardiol; 2020 Jun; 27(3):774-784. PubMed ID: 30039218
[TBL] [Abstract][Full Text] [Related]
22. 11C-PiB PET/CT in nasopharyngeal amyloidosis associated with multiple myeloma.
Ishimura M; Yamamoto Y; Kimura N; Hoshikawa H; Nishiyama Y
Clin Nucl Med; 2015 Feb; 40(2):e161-2. PubMed ID: 25140565
[TBL] [Abstract][Full Text] [Related]
23. Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting.
Banzo I; Jiménez-Bonilla J; Ortega-Nava F; Quirce R; Martínez-Rodríguez I; de Arcocha-Torres M; Rodríguez E; Vázquez JL; Sánchez PJ; Martínez-Amador N; Ibañez-Bravo S; Carril JM
Nucl Med Commun; 2014 Mar; 35(3):238-44. PubMed ID: 24240196
[TBL] [Abstract][Full Text] [Related]
24. Significance of
Minamimoto R; Awaya T; Iwama K; Hotta M; Nakajima K; Hirai R; Okazaki O; Hiroi Y
J Nucl Cardiol; 2020 Feb; 27(1):202-209. PubMed ID: 29589208
[TBL] [Abstract][Full Text] [Related]
25. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.
Abrahamson EE; Padera RF; Davies J; Farrar G; Villemagne VL; Dorbala S; Ikonomovic MD
Amyloid; 2023 Jun; 30(2):169-187. PubMed ID: 36411500
[TBL] [Abstract][Full Text] [Related]
26. Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials.
Andrews KA; Modat M; Macdonald KE; Yeatman T; Cardoso MJ; Leung KK; Barnes J; Villemagne VL; Rowe CC; Fox NC; Ourselin S; Schott JM;
PLoS One; 2013; 8(3):e58816. PubMed ID: 23554933
[TBL] [Abstract][Full Text] [Related]
27. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
[TBL] [Abstract][Full Text] [Related]
28. Early detection of Alzheimer disease: ¹¹C-PiB PET in twins discordant for cognitive impairment.
Scheinin NM; Aalto S; Kaprio J; Koskenvuo M; Räihä I; Rokka J; Hinkka-Yli-Salomäki S; Rinne JO
Neurology; 2011 Aug; 77(5):453-60. PubMed ID: 21700581
[TBL] [Abstract][Full Text] [Related]
29. Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.
Glaudemans AW; Slart RH; Noordzij W; Dierckx RA; Hazenberg BP
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1095-101. PubMed ID: 23474745
[TBL] [Abstract][Full Text] [Related]
30. Clinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control Study.
Seo M; Cha HJ; Kim M; Park SH; Lim JH; Choi Y; Lee YJ; Park SH; Jo JC
Clin Nucl Med; 2019 Sep; 44(9):e503-e509. PubMed ID: 31283608
[TBL] [Abstract][Full Text] [Related]
31. Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma.
Groot C; Tolboom N; Ikonomovic MD; Lammertsma AA; Boon BDC; Barkhof F; Scheltens P; Klunk WE; Rozemuller AJM; Ossenkoppele R; van Berckel BNM
J Alzheimers Dis; 2018; 65(1):71-77. PubMed ID: 30040724
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.
Ossenkoppele R; van der Flier WM; Zwan MD; Adriaanse SF; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van Berckel BN
Neurology; 2013 Jan; 80(4):359-65. PubMed ID: 23255822
[TBL] [Abstract][Full Text] [Related]
33. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
[TBL] [Abstract][Full Text] [Related]
34. Cortical ¹¹C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging".
Scheinin NM; Wikman K; Jula A; Perola M; Vahlberg T; Rokka J; Någren K; Viitanen M; Rinne JO
J Alzheimers Dis; 2014; 41(1):193-202. PubMed ID: 24603945
[TBL] [Abstract][Full Text] [Related]
35. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Jonasson M; Eriksson J; Lubberink M; Almkvist O; Wall A; Antoni G; Nordberg A
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1686-99. PubMed ID: 26996778
[TBL] [Abstract][Full Text] [Related]
36. Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET.
Chen YJ; Rosario BL; Mowrey W; Laymon CM; Lu X; Lopez OL; Klunk WE; Lopresti BJ; Mathis CA; Price JC
J Nucl Med; 2015 Aug; 56(8):1199-205. PubMed ID: 26045309
[TBL] [Abstract][Full Text] [Related]
37. Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.
Cohen AD; Mowrey W; Weissfeld LA; Aizenstein HJ; McDade E; Mountz JM; Nebes RD; Saxton JA; Snitz B; Dekosky S; Williamson J; Lopez OL; Price JC; Mathis CA; Klunk WE
Neuroimage; 2013 May; 71():207-15. PubMed ID: 23353602
[TBL] [Abstract][Full Text] [Related]
38. In vivo amyloid imaging with PET in frontotemporal dementia.
Engler H; Santillo AF; Wang SX; Lindau M; Savitcheva I; Nordberg A; Lannfelt L; Långström B; Kilander L
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):100-6. PubMed ID: 17846768
[TBL] [Abstract][Full Text] [Related]
39. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
